Key practices for our clients
Solidarity Arbitration and Mediation Days 2023
The Solidarity Arbitration and Mediation Days conference will be held on 6–7 December 2023. The event will express the solidarity of the international arbitration and mediation community with all those affected by the war in Ukraine. Wardynski & Partners is a partner of the event.
Senacor Technologies acquires Finanteq
Wardyński & Partners has advised Senacor Technologies AG in its acquisition of the IT company Finanteq S.A. Our assistance included conducting legal due diligence as well as negotiation and drafting of comprehensive transaction documentation.
Wendel and Constantia Flexibles
Wardyński & Partners has advised private equity firm Wendel and its co-shareholders on the sale of Constantia Flexibles to private equity firm One Rock Capital for a price yielding net proceeds for Wendel of c. EUR 1.1 billion. Willkie Farr & Gallagher LLP was the seller’s lead counsel.
Bauer Media Group and an Online Comparison Business Merger
On September 20, 2023, the Bauer Media Group and Netrisk Group announced a significant agreement to merge their online comparison platform (OCP) businesses in the CEE region, which includes Poland's rankomat.pl. Wardyński & Partners played a key advisory role in the Polish aspects of this transaction.
News from Poland—Business & Law, Episode 41: dawn raid
The newest episode of "News from Poland" is about dawn raids, that is unexpected visits from law enforcement. How to prepare for it and how to react? You will hear from Jakub Znamierowski, who represents clients in white-collar crime matters, leads internal investigations and specializes in corporate criminal liability.
Conference: GIC Legal Summit
On October 5-6, 2023, the GIC Legal Summit will be held in Poznań - a unique conference devoted to the legal and business aspects of the gamedev sector. Lena Marcinoska-Boulangé i Monika Górska among the panellists. Wardyński & Partners is a partner of the event.
Joanna Krakowiak and Marcin Rytel examine the planned reform of EU pharmaceutical law—the biggest in 20 years. How will the new regulations affect innovation and access to affordable medicines? Will they reduce the environmental impact of pharmaceutical production?